APPLIED GENETIC TECHNOLOGIES CORPORATION

Company Information
Address APPLIED GENETIC TECHNOLOGIES CRP
12085 RESEARCH DR, STE 110
ALACHUA, FL, 32615-0683


Information

DUNS:

# of Employees: N/A


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. rAAV5-hCNGB3 Gene Therapy for Achromatopsia: Safety and Efficacy in a Dog Model

    Amount: $657,699.00

    DESCRIPTION provided by applicant Complete achromatopsia is an autosomal recessive inherited congenital disorder of retinal cone photoreceptors Patients with complete achromatopsia experience extr ...

    STTRPhase I2013Department of Health and Human Services National Institutes of Health
  2. rAAV5-hCNGB3 Gene Therapy for Achromatopsia: Efficacy in a Dog Model

    Amount: $143,082.00

    DESCRIPTION (provided by applicant): Complete achromatopsia is an inherited retinal disorder characterized by severely reduced visual acuity, nystagmus, severe photophobia, a small central scotoma, e ...

    SBIRPhase I2010Department of Health and Human Services
  3. Molecular Breeding of Gene Therapy Vectors

    Amount: $131,711.00

    DESCRIPTION (provided by applicant): We propose to develop Gene Therapy vectors that are targeted to particular cell membrane receptors, cell types and/or tissues. Development of these precise deliver ...

    SBIRPhase I2003Department of Health and Human Services
  4. TREATMENT OF ANEMIA USING AAV VECTORS

    Amount: $256,725.00

    DESCRIPTION (applicant's abstract): The innovative use of AAV vector technology is proposed to develop milestones essential for the safe treatment of anemia secondary to chronic renal fai ...

    SBIRPhase I2001Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government